{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T19:21:30Z","timestamp":1772047290115,"version":"3.50.1"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.mehy.2020.110476","type":"journal-article","created":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T14:49:52Z","timestamp":1609426192000},"page":"110476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Fecal microbiota transplantation for COVID-19; a potential emerging treatment strategy"],"prefix":"10.1016","volume":"147","author":[{"given":"Seyed Aria","family":"Nejadghaderi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehsan","family":"Nazemalhosseini-Mojarad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid","family":"Asadzadeh Aghdaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2020.110476_b0005","article-title":"Outbreak of a novel coronavirus","volume":"18","author":"Du Toit","year":"2020","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.mehy.2020.110476_b0010","unstructured":"W.H. Organization. Virtual press conference on COVID-19-11 march 2020. https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/transcripts\/who-audio-emergencies-coronavirus-press-conference-full-and-final-11mar2020.pdf?sfvrsn=cb432bb3_2. 2020."},{"key":"10.1016\/j.mehy.2020.110476_b0015","unstructured":"T.W.H.O. (WHO). Situation Report. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/situation-reports\/. 2020, Accessed 31 May 2020."},{"key":"10.1016\/j.mehy.2020.110476_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.bj.2020.05.021","article-title":"Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines","author":"Shih","year":"2020","journal-title":"Biomed J"},{"issue":"2020","key":"10.1016\/j.mehy.2020.110476_b0025","first-page":"1824","article-title":"Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review","volume":"323","author":"Sanders","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.mehy.2020.110476_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104872","article-title":"Efficacy and safety of current therapeutic options for COVID-19 - lessons to be learnt from SARS and MERS epidemic: A systematic review and meta-analysis","volume":"157","author":"Zhong","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.mehy.2020.110476_b0035","first-page":"159","article-title":"Infusion of convalescent plasma is associated with clinical improvement in critically ill patients with COVID-19: A pilot study","volume":"72","author":"Olivares-Gazca","year":"2020","journal-title":"Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion"},{"key":"10.1016\/j.mehy.2020.110476_b0040","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrgastro.2012.156","article-title":"The role of the gut microbiota in nutrition and health","volume":"9","author":"Flint","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.mehy.2020.110476_b0045","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1038\/jp.2010.172","article-title":"The developing intestinal microbiome and its relationship to health and disease in the neonate","volume":"31","author":"Murgas Torrazza","year":"2011","journal-title":"J Perinatology"},{"key":"10.1016\/j.mehy.2020.110476_b0050","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ijfoodmicro.2008.04.012","article-title":"Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production","volume":"125","author":"Candela","year":"2008","journal-title":"Int J Food Microbiol"},{"key":"10.1016\/j.mehy.2020.110476_b0055","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrn3346","article-title":"Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour","volume":"13","author":"Cryan","year":"2012","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.mehy.2020.110476_b0060","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3748\/wjg.15.81","article-title":"Recent advances and remaining gaps in our knowledge of associations between gut microbiota and human health","volume":"15","author":"Mai","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.mehy.2020.110476_b0065","doi-asserted-by":"crossref","first-page":"13780","DOI":"10.1073\/pnas.0706625104","article-title":"Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases","volume":"104","author":"Frank","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.mehy.2020.110476_b0070","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.dld.2015.07.008","article-title":"The human gut microbiota and virome: Potential therapeutic implications","volume":"47","author":"Scarpellini","year":"2015","journal-title":"Digestive Liver Disease"},{"key":"10.1016\/j.mehy.2020.110476_b0075","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.2174\/13816128113196660723","article-title":"Role of yeasts in healthy and impaired gut microbiota: the gut mycome","volume":"20","author":"Ianiro","year":"2014","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.mehy.2020.110476_b0080","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nature11550","article-title":"Diversity, stability and resilience of the human gut microbiota","volume":"489","author":"Lozupone","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2020.110476_b0085","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.pan.2017.09.002","article-title":"The potential role of gut microbiota in pancreatic disease: A systematic review","volume":"17","author":"Memba","year":"2017","journal-title":"Pancreatology"},{"key":"10.1016\/j.mehy.2020.110476_b0090","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/apt.12728","article-title":"Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets","volume":"39","author":"DuPont","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.mehy.2020.110476_b0095","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.3389\/fimmu.2017.01674","article-title":"Influence of Microbiota on Intestinal Immune System in Ulcerative Colitis and Its Intervention","volume":"8","author":"Zhang","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.mehy.2020.110476_b0100","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.3390\/nu11102291","article-title":"Impact of Fecal Microbiota Transplantation on Obesity and Metabolic Syndrome-A Systematic Review","volume":"11","author":"Zhang","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.mehy.2020.110476_b0105","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s00213-019-05248-6","article-title":"Gut microbiota and bipolar disorder: a review of mechanisms and potential targets for adjunctive therapy","volume":"236","author":"Gondalia","year":"2019","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.mehy.2020.110476_b0110","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3109\/00207454.2015.1096271","article-title":"Potential role of gut microbiota and tissue barriers in Parkinson's disease and amyotrophic lateral sclerosis","volume":"126","author":"Fang","year":"2016","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.mehy.2020.110476_b0115","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1038\/ajg.2012.251","article-title":"Should we standardize the 1,700-year-old fecal microbiota transplantation?","volume":"107","author":"Zhang","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"2015","key":"10.1016\/j.mehy.2020.110476_b0120","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/j.gastro.2015.05.008","article-title":"Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook","volume":"149","author":"Kelly","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mehy.2020.110476_b0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002503","article-title":"Fecal Transplants: What Is Being Transferred?","volume":"14","author":"Bojanova","year":"2016","journal-title":"PLoS Biol"},{"key":"10.1016\/j.mehy.2020.110476_b0130","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ebiom.2019.02.023","article-title":"Bacterial viability in faecal transplants: Which bacteria survive?","volume":"41","author":"Papanicolas","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.mehy.2020.110476_b0135","doi-asserted-by":"crossref","first-page":"e00322","DOI":"10.1128\/mBio.00322-16","article-title":"Transfer of Viral Communities between Human Individuals during Fecal Microbiota Transplantation","volume":"7","author":"Chehoud","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.mehy.2020.110476_b0140","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/apt.14201","article-title":"Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection","volume":"46","author":"Quraishi","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.mehy.2020.110476_b0145","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3389\/fcimb.2016.00015","article-title":"The New Era of Treatment for Obesity and Metabolic Disorders: Evidence and Expectations for Gut Microbiome Transplantation","volume":"6","author":"Jayasinghe","year":"2016","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.mehy.2020.110476_b0150","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/hep.29306","article-title":"Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial","volume":"66","author":"Bajaj","year":"2017","journal-title":"Hepatology (Baltimore, MD)"},{"key":"10.1016\/j.mehy.2020.110476_b0155","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1177\/0300060519854913","article-title":"Improvement of Good\u2019s syndrome by fecal microbiota transplantation: the first case report","volume":"47","author":"Jagessar","year":"2019","journal-title":"J Int Med Res"},{"key":"10.1016\/j.mehy.2020.110476_b0160","doi-asserted-by":"crossref","first-page":"257","DOI":"10.5946\/ce.2015.117","article-title":"Fecal Microbiota Transplantation: Current Applications, Effectiveness, and Future Perspectives","volume":"49","author":"Choi","year":"2016","journal-title":"Clin Endosc"},{"key":"10.1016\/j.mehy.2020.110476_b0165","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/ibd.20176","article-title":"Adherent-invasive Escherichia coli in inflammatory bowel disease","volume":"13","author":"Rolhion","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.mehy.2020.110476_b0170","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-2036.2009.04034.x","article-title":"Association between entero-hepatic Helicobacter species and Crohn's disease: a prospective cross-sectional study","volume":"30","author":"Laharie","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.mehy.2020.110476_b0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058825","article-title":"The microaerophilic microbiota of de-novo paediatric inflammatory bowel disease: the BISCUIT study","volume":"8","author":"Hansen","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mehy.2020.110476_b0180","doi-asserted-by":"crossref","first-page":"14805","DOI":"10.3748\/wjg.v20.i40.14805","article-title":"Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease","volume":"20","author":"Wang","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.mehy.2020.110476_b0185","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1089\/aid.2017.0268","article-title":"Altered Gut Microbiota in HIV Infection: Future Perspective of Fecal Microbiota Transplantation Therapy","volume":"35","author":"Kang","year":"2019","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.mehy.2020.110476_b0190","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2020.110476_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.198018","article-title":"Gut microbiota and Covid-19- possible link and implications","volume":"285","author":"Dhar","year":"2020","journal-title":"Virus Res"},{"key":"10.1016\/j.mehy.2020.110476_b0200","doi-asserted-by":"crossref","first-page":"766","DOI":"10.14309\/ajg.0000000000000620","article-title":"Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study","volume":"115","author":"Pan","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.mehy.2020.110476_b0205","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2020-000417","article-title":"Novelty in the gut: a systematic review and meta-analysis of the gastrointestinal manifestations of COVID-19","volume":"7","author":"Suresh Kumar","year":"2020","journal-title":"BMJ Open Gastroenterol"},{"key":"10.1016\/j.mehy.2020.110476_b0210","article-title":"Gut microbiota may underlie the predisposition of healthy individuals to COVID-19","author":"Gou","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.mehy.2020.110476_b0215","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/cmi.2015.74","article-title":"The cytokine storm of severe influenza and development of immunomodulatory therapy","volume":"13","author":"Liu","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.mehy.2020.110476_b0220","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/jmv.20255","article-title":"An interferon-gamma-related cytokine storm in SARS patients","volume":"75","author":"Huang","year":"2005","journal-title":"J Med Virol"},{"key":"10.1016\/j.mehy.2020.110476_b0225","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.cell.2016.10.020","article-title":"Linking the Human Gut Microbiome to Inflammatory Cytokine Production Capacity","volume":"167","author":"Schirmer","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.mehy.2020.110476_b0230","doi-asserted-by":"crossref","first-page":"710","DOI":"10.2174\/1381612824666180116163411","article-title":"Probiotics and Paraprobiotics in Viral Infection: Clinical Application and Effects on the Innate and Acquired Immune Systems","volume":"24","author":"Kanauchi","year":"2018","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.mehy.2020.110476_b0235","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2019.00256","article-title":"Microbiota and Its Role on Viral Evasion: Is It With Us or Against Us?","volume":"9","author":"Dom\u00ednguez-D\u00edaz","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.mehy.2020.110476_b0240","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/FJC.0000000000000307","article-title":"ACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease Therapy","volume":"66","author":"Cole-Jeffrey","year":"2015","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.mehy.2020.110476_b0245","article-title":"Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization","author":"Zuo","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mehy.2020.110476_b0250","article-title":"[Management of corona virus disease-19 (COVID-19): the Zhejiang experience], Zhejiang da xue xue bao","volume":"49","author":"Xu","year":"2020","journal-title":"Yi xue ban = J Zhejiang University. Med Sci"},{"key":"10.1016\/j.mehy.2020.110476_b0255","article-title":"Lung microbiota in the acute respiratory disease: from coronavirus to metabolomics","volume":"9","author":"Fanos","year":"2020","journal-title":"J Pediatric Neonatal Individualized Med (JPNIM)"},{"key":"10.1016\/j.mehy.2020.110476_b0260","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1002\/1873-3468.12421","article-title":"Linking microbiota and respiratory disease","volume":"590","author":"Hauptmann","year":"2016","journal-title":"FEBS Lett"},{"key":"10.1016\/j.mehy.2020.110476_b0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008578","article-title":"Disordered Microbial Communities in Asthmatic Airways","volume":"5","author":"Hilty","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mehy.2020.110476_b0270","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jinf.2020.05.046","article-title":"Co-infections in people with COVID-19: a systematic review and meta-analysis","volume":"81","author":"Lansbury","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.mehy.2020.110476_b0275","unstructured":"Zhang F. Washed Microbiota Transplantation for Patients With 2019-nCoV Infection. https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT04251767; 2020."},{"key":"10.1016\/j.mehy.2020.110476_b0280","unstructured":"Buehler SBPKSBPK, Microbiota in COVID-19 Patients for Future Therapeutic and Preventive Approaches (MICRO-COV). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04410263; 2020."},{"key":"10.1016\/j.mehy.2020.110476_b0285","unstructured":"Nseir S, Bacterial and Fungal Microbiota of Patients With Severe Viral Pneumonia With COVID-19 (MICROVID). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04359706; 2020."},{"key":"10.1016\/j.mehy.2020.110476_b0290","doi-asserted-by":"crossref","DOI":"10.1111\/jgh.15002","article-title":"Cost-effectiveness analysis of fecal microbiota transplantation for recurrent Clostridium difficile infection in patients with inflammatory bowel disease","author":"You","year":"2020","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.mehy.2020.110476_b0295","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S2055-6640(20)30018-2","article-title":"Minimum costs to manufacture new treatments for COVID-19","volume":"6","author":"Hill","year":"2020","journal-title":"J Virus Erad"},{"key":"10.1016\/j.mehy.2020.110476_b0300","article-title":"Systematic Review: Adverse Events of Fecal Microbiota Transplantation","volume":"11","author":"Wang","year":"2016","journal-title":"PLoS ONE"},{"issue":"Suppl 1","key":"10.1016\/j.mehy.2020.110476_b0305","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.jfma.2018.08.011","article-title":"Fecal microbiota transplantation: Review and update","volume":"118","author":"Wang","year":"2019","journal-title":"J Formosan Med Assoc = Taiwan yi zhi"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720333673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720333673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:22:26Z","timestamp":1759692146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987720333673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":61,"alternative-id":["S0306987720333673"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2020.110476","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fecal microbiota transplantation for COVID-19; a potential emerging treatment strategy","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2020.110476","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110476"}}